October 10, 2024, 09:51 AM - 8 min read
The dietary supplement market has sought to cash in on the GLP-1 demand with pills, teas, extracts and all manner of other products that claim to produce similar effects as the brand names at a much lower price.
Read moreSeptember 27, 2024, 10:26 AM - 5 min read
The arrival of GLP-1 analogue drugs (such as Wegovy) marked a huge shift in the weight loss drug market. These drugs have been shown to lead to significant weight loss in users – as much as 15% or more of their body weight in clinical trials.
Read moreAugust 7, 2024, 10:58 AM - 2 min read
Originally developed as a treatment for type 2 diabetes, so-called “skinny jabs” containing the appetite-suppressant semaglutide are a relatively recent innovation.
Read moreJuly 6, 2024, 12:08 PM - 2 min read
Patients using diabetes and weight-loss drugs Ozempic and Wegovy might face a higher risk of developing a serious eye condition. This condition, called a stroke of the optic nerve or NAION, can lead to blindness, as per new research findings.
Read more